Products for Research Use Only
RegisterLogin

Besufetamig

CAT: 0804-HY-P991122-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991122-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers[1].
CAS Number
3037124-22-1
UNSPSC
12352203
Target
CD3; PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Purity
99.98
Smiles
[Besufetamig]
Molecular Weight
(146.01 kDa)
References & Citations
[1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T9901A-928-01Besufetamig
WA2513Research Grade besufetamig
PX-TA2449-01Besufetamig Biosimilar - Research Grade
GTR18695443-01Besufetamig Human Monoclonal Antibody
A137469Besufetamig Biosimilar (Monoclonal, IgG1, Kappa)

Popular Products